Simon Carding

Simon R. Carding is a Professor of Mucosal Immunology at Norwich Medical School, University of East Anglia, and the Research Leader of the Gut Biology Research Programme, which is part of the research collaborative, Gut Health and Food Safety (GHFS) Programme.

Articles and Blog Entries

 * 2016, Do the Answers to ME/CFS lie Within Our Gut?
 * 2014, Crowdsourcing raises vital funds for ME research into 'leaky gut syndrome'
 * 2013, Professor Simon Carding, Phd

Talks and Interviews

 * 2 Jun 2017, Speaker at the 12th Invest in ME International ME Conference on "Panel Discussion led by Professor Simon Carding with PhD students from Quadram Institute Biosciences" - DVD available
 * 28 Jan 2017, BBC: Interview with prof. Simon Carding on ME/CFS
 * 26 Jan 2017, BBC Look East: Research in Norwich could offer ME/CFS breakthrough
 * Jan 2017, Public talk in Norwich on ME/CFS biomedical research hosted by Institute Food Research and [[Invest in ME] Research]
 * 2016, Speaker at the 11th [[Invest in ME International ME Conference] on The European ME Research Group (EMERG)] DVD available
 * 2015, Speaker at the 10th [[Invest in ME International ME Conference] No speech title given but the topic was about whether there is evidence of a leaky gut in ME patients] DVD available
 * 2014, Speaker at the 9th [[Invest in ME International ME Conference] No speech title given but the topic was about whether there is evidence of a leaky gut in ME patients] DVD available
 * 2013, Speaker at the 8th [[Invest in ME International ME Conference] No speech title given but the topic was about whether there is evidence of a leaky gut in ME patients] DVD available
 * 2011, Speaker at the 6th [[Invest in ME International ME Conference] on UK Research: Genome Sequencing, Virology & Immunology for ME/CFS] DVD available

Research Related to ME/CFS

 * A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?"Abtract: '...This article provides a comprehensive review of the current evidence supporting an infectious aetiology for ME/CFS leading us to propose the novel concept that the intestinal microbiota and in particular members of the virome are a source of the 'infectious' trigger of the disease. Such an approach has the potential to identify disease biomarkers and influence therapeutics, providing much-needed approaches in preventing and managing a disease desperately in need of confronting.'"

Online Presence

 * Simon Carding blog at GHFS